M J Langman. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Amylopectin/therapeutic useAntacids/therapeutic useBismuth/therapeutic useCarbenoxolone/therapeutic useCholestyramine Resin/therapeutic useDuodenal Ulcer/drug therapyEstrogens/therapeutic useFatty Acids, Unsaturated/therapeutic useGlycyrrhizaHistamine H2 Antagonists/therapeutic useHumansImidazoles/therapeutic useMetoclopramide/therapeutic useParasympatholytics/therapeutic usePlants, MedicinalProstaglandins, Synthetic/therapeutic useRecurrenceStomach Ulcer/drug therapyZinc/therapeutic use
Substances: See more » AntacidsEstrogensFatty Acids, UnsaturatedHistamine H2 AntagonistsImidazolesParasympatholyticsProstaglandins, SyntheticCholestyramine ResinAmylopectinZincMetoclopramideCarbenoxoloneBismuth
Year: 1977 PMID: 19225 DOI: 10.2165/00003495-197714020-00002
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546